* P3 Health Partners Inc PIII.OQ PIII.O is expected
to show a
rise in quarterly revenue when it reports results on August 7.
* The Chicago Illinois-based company is expected to report
a
12.8% increase in revenue to $303.934 million from $269.45
million a year ago, according to the mean estimate from 4
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for P3 Health Partners
Inc is
for a loss of 13 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for P3 Health
Partners Inc is $4, above its last closing price of $2.22.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Mar. 31 2023 -0.63 -0.67 -0.22 Beat 67.4
Dec. 31 2023 -0.91 -2.26 Missed -148.4
Sep. 30 2022 -0.47 -0.46 -0.27 Beat 41.7
Jun. 30 2022 -0.16 -0.21 Missed -31.2
Mar. -0.12 -0.25 Missed -102.7
31 2022
Dec. 31 2021 -0.24 -0.24 Met 1.4
This summary was machine generated August 5 at 02:02 GMT. All
figures in US dollars unless otherwise stated